A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.

نویسندگان

  • Eline J M Bertrums
  • Arjan Buijs
  • Martine van Grotel
  • Natasja Dors
  • Jasmijn D E de Rooij
  • Valerie de Haas
  • Sanne Hopman
  • Marjolijn C J Jongmans
  • C M Zwaan
  • Marry M van den Heuvel-Eibrink
چکیده

Transient myeloproliferative disorder (TMD) is a leukemia type that occurs typically in newborns. In Down syndrome, TMD is referred to as transient abnormal myelopoiesis (TAM).32 Recently, transientness has also been reported in acute myeloid leukemia patients with germline trisomy 21 mosaicism, and even in cases with somatic trisomy 21, with or without GATA1 mutations. TMD cases without trisomy 21 are rare, and recurrent genetic aberrations that aid in clinical decision-making are scarcely described. We describe here a TMD patient without trisomy 21 or GATA1 mutation in whom single-nucleotide polymorphism analysis of leukemic blasts revealed a novel combined submicroscopic deletion (5q31.1-5q31.3 and 8q23.2q24).

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Liver Vascularity and Function in Fetuses with Trisomy 21

Among the clinical forms of Down syndrome there is a wide spectrum, which includes variable degrees of hematological anomalies. The characteristic type of leukemia for these children is acute megakaryoblastic leukemia (AMKL), which has an incidence 500 times higher in children with Down syndrome compared to normal pediatric population. Between 4 and 10% of the newborns with Down syndrome will d...

متن کامل

GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.

Children with constitutional trisomy 21 (Down syndrome) have an approximately 500-fold increased risk of developing acute megakaryoblastic leukemia (AMKL), a form of acute myeloid leukemia. Unique to newborn infants with Down syndrome is a transient leukemia (TL), also referred to as transient myeloproliferative syndrome, that undergoes spontaneous remission in the majority of cases but in appr...

متن کامل

Malignancy in children with trisomy 21.

Patients with Down syndrome (DS) display a unique spectrum of malignancies, with a 10- to 20-fold higher risk of acute leukemias, and a markedly lower incidence of solid tumors. This review discusses the current understanding of the basis for this distinctive pattern of cancer incidence and the clinical and biologic features of the malignant disorders most frequent in DS individuals: transient ...

متن کامل

The proto-oncogene ERG in megakaryoblastic leukemias.

Aneuploidy is one of the hallmarks of cancer. Acquired additions of chromosome 21 are a common finding in leukemias, suggesting a contributory role to leukemogenesis. About 10% of patients with a germ line trisomy 21 (Down syndrome) are born with transient megakaryoblastic leukemia. We and others have shown acquired mutations in the X chromosome gene GATA1 in all these cases. The gene or genes ...

متن کامل

Blood Spotlight The biology of pediatric acute megakaryoblastic leukemia

Acute megakaryoblastic leukemia (AMKL) is a subtype of acute myeloid leukemia (AML) characterized by abnormal megakaryoblasts that expressplatelet-specific surfaceglycoprotein.Bonemarrowbiopsy frequently demonstrates extensive myelofibrosis, often making aspiration in these patients difficult. AMKL is extremely rare in adults, occurring in only 1% of AML patients. This is in contrast to childre...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Pediatric blood & cancer

دوره 64 3  شماره 

صفحات  -

تاریخ انتشار 2017